ArticlePediatric research2026
Hemodynamic changes in preterm neonates with respiratory distress syndrome: high-flow nasal cannula versus nasal continuous positive airway pressure-a randomized controlled trial.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04238273 (Hemodynamic Changes With Heated, Humidified High Flow Nasal Cannula), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Hemodynamic Changes With Heated, Humidified High Flow Nasal Cannula (HHHFNC) Versus Nasal Continuous Positive Airway Pressure (nCPAP) for Respiratory Support of Preterm Neonates
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNon-invasive ventilation (NIV) in the form of heated humidified, high-flow nasal cannula (HHHFNC) or nasal continuous positive airway pressure (nCPAP) is widely used in preterm neonates with respiratory distress syndrome (RDS). We aimed to evaluate the impact of HHHFNC and nCPAP on cardiac, cerebral, and mesenteric hemodynamics.
methodsOne hundred twenty-three hemodynamically stable, low birth weight preterm neonates <34 weeks with RDS who needed NIV were randomized to receive either HHHFNC or NCPAP. Echocardiographic parameters, including superior vena cava (SVC) flow, left ventricular output (LVO), and right ventricular output (RVO), as well as anterior cerebral artery (ACA) resistance index, and superior mesenteric artery (SMA) flow velocity and resistance, were assessed 1 h before and 1 h after weaning off respiratory support.
resultsSMA flow increased after discontinuing HHHFNC and nCPAP (P˂0.001 and 0.001, respectively). SVC flow, RVO, LVO, and ACA resistance index did not show significant changes in either group. A negative correlation was observed between the highest positive end-expiratory pressure and SMA flow velocity (P = 0.002).
conclusionBoth HHHFNC and nCPAP do not impact cardiac or cerebral hemodynamics. However, both modalities result in a reversible reduction in mesenteric blood flow. This trial was registered at ClinicalTrials.gov, identifier: NCT04238273. IMPACT: Non-invasive ventilation (NIV), such as heated humidified, high-flow nasal cannula (HHHFNC) or nasal continuous positive airway pressure (nCPAP), is widely used in preterm neonates with respiratory distress syndrome (RDS). Using the current design, HHHFNC and nCPAP do not impact cardiac or cerebral hemodynamics. Both modalities result in a reduction in mesenteric blood flow. These changes are reversible upon discontinuation of respiratory therapy. A negative correlation was observed between positive end-expiratory pressure in nCPAP and SMA flow velocity. The use of HHHFNC and nCPAP is hemodynamically safe in neonates with RDS.
Identifiers
42243499What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.